Literature DB >> 18207070

Antiphospholipid antibodies and malignancy.

Chi Pham1, Yu-Min Shen.   

Abstract

Antiphospholipid antibody syndrome is characterized clinically by venous or arterial thrombosis, recurrent fetal loss, or placental insufficiency in women. This article describes the prevalence of malignancy, the manifestations, and the prognosis for this condition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207070     DOI: 10.1016/j.hoc.2007.10.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  2 in total

1.  Marginal zone lymphoma-associated antiphospholipid antibodies successfully treated with bendamustine rituximab.

Authors:  Ziyang Liu; Merry Markham; Molly W Mandernach
Journal:  BMJ Case Rep       Date:  2019-03-14

Review 2.  Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome.

Authors:  Juan J Fierro; Manuela Velásquez; Angela P Cadavid; Karina de Leeuw
Journal:  Am J Reprod Immunol       Date:  2021-12-04       Impact factor: 3.777

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.